As per the research report, the Asia Pacific Body Composition Analyzers Market was worth USD 88.84 million in 2022. It is projected to be growing at a CAGR of 16.5%, to touch USD 190.66 million by 2027.
Body composition analyzers (BCAs) are devices that aid in measuring body composition. Body composition refers to the proportions of fat and lean mass present in the body.
The functioning of a Body Composition Analyzers involves measuring the percentages of fat, bone, water, and muscle present in the human body. BCAs are useful in determining leanness since muscle mass takes up lesser space than fat by weight, making it difficult to judge body fat without accurate measurements.
The increasing awareness majorly drives the growth of the Asia-Pacific Body Composition Analyzers Market among the people about the problems associated with obesity and the benefits of maintaining appropriate fitness levels. Other factors driving the Asia-Pacific market include the rising use of BCAs in the sports and fitness industry and increasing government expenditure to increase awareness about physical activity and encourage health consciousness among the populace.
However, the high cost of the equipment and the inaccuracy of various analyzers are some of the constraints faced by the market.
This research report on the APAC Body Composition Analyzers Market has been segmented and sub-segmented into the following categories:
Geographically, Asia-Pacific Body Composition Analyzers Market is expected to grow at the highest CAGR due to the availability of massive untapped markets and enormous population base coupled with increasing health & fitness awareness, which is reflected in its robust CAGR of more than 16%. Factors such as growing disposable incomes and government support in countries such as India and China are expected to lead the growth of the market in this region.
Noteworthy companies leading in the APAC Body Composition Analyzers Market profiled in the report are InBody Co., Ltd (South Korea), Tanita Corporation (Japan), Omron Corporation (Japan), Hologic, Inc. (U.S.), and GE Healthcare (U.S.), among others.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com